HRL · Hormel Foods Corp /De/
$19.92
+0.07 (+0.35%)
At close · Sep 30
Return incl. dividend (before tax)
Market Cap
$10.85B
Shares
550.35M
Volume · Sep 30
4.94M
Avg daily vol (3M)
4.47M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$19.85
Open$19.85
Day$19.57–19.96
52W close$19.71–26.51
Avg vol 30d5.4M
Short int20.8M · 3.8% float · 4.7d
Short vol61%
Last earningsAug 27, 2026
DataJan 2020–Sep 2026
Filing10-Q · Aug 27
Up next
Next earnings call
Nov 23, 2026
Est · unconfirmed
· in 8 wks
filed Aug 27, 2026
call held Aug 27, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$12.15B
Trailing 12 months
Net income (TTM)
$342.71M
Trailing 12 months
Revenue growth YoY
-2.4%
Year over year
Operating margin
4.7%
Trailing 12 months
P / E (TTM)
31.5
Trailing earnings · reciprocal yield 3.2%
FCF yield
7.2%
TTM · current market cap
Return on invested capital
3.8%
Trailing 12 months
Net cash
−$1.99B
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+0.1%
Year over year · more shares
Price change (1Y)
-19.4%
Trailing year
Short interest
3.8%
Latest settlement · 4.7 days to cover
AI Brief
Q3 FY26 earnings call · Aug 27, 2026
Q3 FY26
TL;DR. Hormel delivered adjusted EPS of $0.37 in Q3, up 6% year-over-year, on adjusted operating margin expansion of 60 bps to 9.0%, and is raising and narrowing its FY2026 adjusted EPS guidance to $1.45–$1.51 (from $1.43–$1.51), while full-year GAAP diluted EPS guidance was cut sharply to $1.06–$1.12 from $1.28–$1.37 due to one-time charges tied to the Brazil divestiture, an Indonesia impairment, and a litigation settlement; the company also announced the Brazil divestiture and a CEO transition.
Bullish
- + Raised and narrowed FY2026 adjusted EPS guidance to $1.45–$1.51 (from $1.43–$1.51), implying 6%–10% growth.
- + Adjusted EPS grew 6% to $0.37 in Q3 despite a 2% organic net sales decline.
- + Adjusted operating margin expanded 60 bps to 9.0% versus prior year.
- + Foodservice delivered its 12th consecutive quarter of organic net sales growth, with segment profit up 3%.
Bearish
- − FY2026 GAAP diluted EPS guidance was cut to $1.06–$1.12 from $1.28–$1.37 due to one-time charges.
- − Q3 GAAP results were hit by $56M Brazil divestiture loss, $48M Indonesia impairment, and $38M litigation settlement; GAAP operating margin fell to 3.7% from 7.9%.
- − Organic net sales declined 2% in Q3 with retail organic volume down 9%, as consumer pressure, pricing elasticity, and portfolio-shaping weighed on volume.
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Very Bearish
Fundamentals
Weak
Quant / Vol
Moderate
Market backdrop
VIX 16 · calm
Equity put/call 0.38
Technical
price trend
50 / 200-day cross
Death cross
Price vs 200-day avg
−15%
below
Price vs 50-day avg
−14%
below
RSI (14)
27
oversold
MACD trend
Positive
52-week position
2%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−9%
trailing
6-month return
−8%
trailing
YTD return
−16%
this year
Relative strength
−21%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
Death cross
50d $23 › 200d $23 — 200d above 50d
Institutional flow
Distributing
-2% holders QoQ · +91 funds added
Insider flow
Distributing
Net -$495.2K over 90 days · 100% sells
Short interest
Rising
3.79% of float · ▲ +0.4% MoM · 4.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
630 holders — mid 3-yr range
Squeeze score
52
elevated · 0–100
Fundamentals
Revenue growth
+2%
Y/Y
Gross margin
16%
contracting
EPS growth
−41%
Y/Y
Free cash flow
$534.3M
Valuation
P/E 31.3
rich
Balance sheet
$2.2B
net debt
Quant / Vol
risk profile
Volatility
29%
annualized · 1-yr
Max drawdown
−26%
past year
ATR
2.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Aug 27, 2026
Net sales
· fiscal 2026
Initiated
$12.1B – $12.2B
prior FY $12.11B
midpoint +0.4% Y/Y
Organic Net Sales Growth Rate
· fiscal 2026
Initiated
1% – 2%
Adjusted operating income
· fiscal 2026
Initiated
$1.08B – $1.12B
Operating income
· fiscal 2026
Initiated
$830M – $870M
Diluted earnings per share
· fiscal 2026
Initiated
$1.06 – $1.12
prior FY $0.87
midpoint +25.3% Y/Y
Guided vs delivered
· last 8 settled
Net Sales
Fiscal 2024
guided $12.2B – $12.5B
$11.92B
Miss −3.5%
Diluted Net Earnings per Share (GAAP)
Fiscal 2024 Outlook
guided $1.45 – $1.55
$1.47
In line
Net sales
fiscal 2022
guided $11.7B – $12.5B
$12.46B
In line
Diluted earnings per share
fiscal 2022
guided $1.87 – $2.03
$1.82
Miss −6.7%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
Death cross
Bearish
Price vs 200-day avg
−15%
Bearish
Price vs 50-day avg
−14%
Bearish
RSI (14)
27
Neutral
MACD trend
Positive
Bullish
52-week position
2%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 4 of 6
Trend (MA cross)
Death cross
50d $23 › 200d $23 — 200d above 50d
Institutional flow
Distributing
-2% holders QoQ · +91 funds added
Insider flow
Distributing
Net -$495.2K over 90 days · 100% sells
Short interest
Rising
3.79% of float · ▲ +0.4% MoM · 4.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
630 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $20
Now $20 · 2%
Range high $27
vs 200-day avg -15%
vs 50-day avg -14%
50-day below 200-day death cross
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted Diluted Earnings Per Share (Non-GAAP) non-GAAP | $1.11 | Nine Months Ended July 26, 2026 | — |
| Adjusted earnings before income taxes non-GAAP | 258M | Q3 FY2026 | — |
GAAP → non-GAAP reconciliationGAAP Earnings Before Income Taxes (GAAP) 103.16M
+12.24M Transform and Modernize Initiative
+57.38M (Gain) Loss on Divestitures
-26K Corporate Restructuring Plan
+0K Consulting Agreement
+37.5M Litigation Settlements
+48.22M Impairments
= Adjusted Earnings Before Income Taxes 258.47M
|
|||
| Adjusted Net Earnings Attributable to Hormel Foods Corporation (Non-GAAP) non-GAAP | $609.16M | Nine Months Ended July 26, 2026 | — |
| Adjusted Operating Income (Non-GAAP) non-GAAP | $807.29M | Nine Months Ended July 26, 2026 | — |
| Adjusted operating margin non-GAAP | 9% | Q3 FY2026 | — |
| Adjusted Segment Profit non-GAAP | 18.99M | Quarter Ended July 26, 2026 filing | — |
| Adjusted Segment Profit - Foodservice non-GAAP | $144.48M | Quarter Ended July 26, 2026 filing | — |
| Adjusted Segment Profit - International non-GAAP | $18.99M | Quarter Ended July 26, 2026 filing | — |
| Adjusted Segment Profit - Retail non-GAAP | $118.07M | Quarter Ended July 26, 2026 filing | — |
| Adjusted SG&A non-GAAP | 216.86M | Quarter Ended July 26, 2026 filing | — |
GAAP → non-GAAP reconciliationGAAP SG&A 323.5M
-11.79M Transform and Modernize Initiative
-57.38M Gain (Loss) on Divestitures
+26K Corporate Restructuring Plan
+0K Consulting Agreement
-37.5M Litigation Settlements
= Adjusted SG&A 216.86M
|
|||
| Adjusted SG&A as a Percent of Net Sales (Non-GAAP) non-GAAP | 7.8% | Nine Months Ended July 26, 2026 | — |
| Adjusted Total Segment Profit non-GAAP | $281.53M | Quarter Ended July 26, 2026 filing | — |
| Advertising investments | $34M | the third quarter of fiscal 2026 filing | — |
| Non-GAAP % Change non-GAAP | -3.9% | Nine Months Ended July 26, 2026 | — |
| Non-GAAP Organic Net Sales non-GAAP | $3.01B | the three months ended July 26, 2026 filing | — |
| Non-GAAP Organic Volume (lbs.) non-GAAP | 1.04B | the three months ended July 26, 2026 filing | — |
| Organic Net Sales - Foodservice non-GAAP | $985.12M | Quarter Ended July 26, 2026 filing | — |
| Organic Net Sales - International non-GAAP | $186.95M | Quarter Ended July 26, 2026 filing | — |
| Organic Net Sales - Retail non-GAAP | $1.84B | Quarter Ended July 26, 2026 filing | — |
| Organic Volume - Retail non-GAAP | 709.37M | Quarter Ended July 26, 2026 filing | — |
| Segment Profit | $144.48M | the three months ended July 26, 2026 filing | — |
| Total Volume (lbs.) | 2.97B | Nine Months Ended July 26, 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Packaged Foods — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
HRL
this stock
Hormel Foods Corp /De/
|
$10.85B | -16.2% | +1.6% | 31.3 | 3.8% |
|
JBS
Jbs N.V.
|
$38.06B | -21.2% | — | — | 1.2% |
|
KHC
Kraft Heinz Co
|
$28.02B | -3.3% | -0.1% | — | 7.9% |
|
GIS
General Mills Inc
|
$17.99B | -27.3% | +4.1% | — | 8.4% |
|
SJM
J M SMUCKER Co
|
$12.93B | +23.4% | +3.7% | — | 4.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| HRL | -2.4% | -9.2% | -8.3% | -9.2% | -16.2% |
| SPY | -1.2% | -0.4% | +13.1% | -0.4% | +12.1% |
| vs SPY | -1.2% | -8.8% | -21.3% | -8.8% | -28.3% |
Capital returns
Declared · upcoming
$0.2925
/ share · ex Oct 13, 2026
Paid (TTM)
$0.00
/ share · 0 payouts
Dividend yield (TTM, derived)
— · no payout in the trailing year
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.